Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Biotech Investing
FDA Approves LUMAKRAS , The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Biotech Investing
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Zeposia® , an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis1 Biotech Investing
HempFusion CBD and Probulin Probiotics Partner with Two-Time Olympic Gold Medalist and Five-Time World Champion, Kaillie Humphries Biotech Investing
AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society Annual Scientific Meeting Biotech Investing
Bristol Myers Squibb to Take Part in Bernstein's 37th Annual Strategic Decisions Conference Biotech Investing
